Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
Open Access
- 29 November 2019
- journal article
- review article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 7 (X), 1-9
- https://doi.org/10.14218/jcth.2019.00028
Abstract
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the developed world, with a global prevalence of around 25%. NAFLD is considered to be the hepatic manifestation of metabolic syndrome and is strongly associated with obesity, insulin resistance and dyslipidemia. Insulin resistance plays a pivotal role in the development of NAFLD-related dyslipidemia, which ultimately increases the risk of premature cardiovascular diseases, a leading cause of morbidity and mortality in patients with NAFLD. Insulin affects hepatic glucose and lipid metabolism by hepatic or extrahepatic pathways. Aside from insulin resistance, several other factors also contribute to the pathogenesis of atherogenic dyslipidemia in patients with NAFLD. These include diet composition, gut microbiota and genetic factors, to name a few. The identification of potentially modifiable risk factors of NAFLD is of importance, so as to target those who may benefit from lifestyle changes and to help develop targeted therapies that decrease the risk of cardiovascular diseases in patients with NAFLD.Keywords
This publication has 123 references indexed in Scilit:
- Intrahepatic Diacylglycerol Content Is Associated With Hepatic Insulin Resistance in Obese SubjectsGastroenterology, 2012
- The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humansJCI Insight, 2012
- A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolismNature, 2012
- Cellular mechanism of insulin resistance in nonalcoholic fatty liver diseaseProceedings of the National Academy of Sciences of the United States of America, 2011
- Brain Insulin Controls Adipose Tissue Lipolysis and LipogenesisCell Metabolism, 2011
- Apolipoprotein C3 Gene Variants in Nonalcoholic Fatty Liver DiseaseThe New England Journal of Medicine, 2010
- Non-alcoholic fatty liver disease: The mist gradually clearsJournal of Hepatology, 2008
- Fructose consumption as a risk factor for non-alcoholic fatty liver diseaseJournal of Hepatology, 2008
- The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndromeProceedings of the National Academy of Sciences of the United States of America, 2007
- Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver diseaseJCI Insight, 2007